Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1233 ARTÍCULOS , VIENDO DEL 991 AL 1005

Alzheimer's disease as oligomeropathy

Ono K.

Neurochem Int. 2018 Oct;119:57-70. doi: 10.1016/j.neuint.2017.08.010. Epub 2017 Aug 16.

Three-Dimensional Models of the Human Brain Development and Diseases

Jorfi M, D'Avanzo C, Kim DY, Irimia D.

Adv Healthc Mater. 2018 Jan;7(1):10.1002/adhm.201700723. doi: 10.1002/adhm.201700723. Epub 2017 Aug 28.

Targeting NAD(+) degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty

Ruan Q, Ruan J, Zhang W, Qian F, Yu Z.

Pharmacol Res. 2018 Feb;128:345-358. doi: 10.1016/j.phrs.2017.08.010. Epub 2017 Aug 25.

Transcriptional Effects of ApoE4: Relevance to Alzheimer's Disease

Theendakara V, Peters-Libeu CA, Bredesen DE, Rao RV.

Mol Neurobiol. 2018 Jun;55(6):5243-5254. doi: 10.1007/s12035-017-0757-2. Epub 2017 Sep 6.

Modulation of γ- and β-Secretases as Early Prevention Against Alzheimer's Disease

Voytyuk I, De Strooper B, Chávez-Gutiérrez L.

Biol Psychiatry. 2018 Feb 15;83(4):320-327. doi: 10.1016/j.biopsych.2017.08.001. Epub 2017 Aug 10.

Conceptual elaboration versus direct lexical access in WAIS-similarities: differential effects of white-matter lesions and gray matter volumes

Fernaeus SE, Hellström Å.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2018 Nov;25(6):893-903. doi: 10.1080/13825585.2017.1378310. Epub 2017 Sep 18.

Therapeutic peptides for CNS indications: Progress and challenges

Morimoto BH.

Bioorg Med Chem. 2018 Jun 1;26(10):2859-2862. doi: 10.1016/j.bmc.2017.09.011. Epub 2017 Sep 9.

Reduced brain insulin signaling: A seminal process in Alzheimer's disease pathogenesis

Bloom GS, Lazo JS, Norambuena A.

Neuropharmacology. 2018 Jul 1;136(Pt B):192-195. doi: 10.1016/j.neuropharm.2017.09.016. Epub 2017 Sep 29.

Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise

van Dyck CH.

Biol Psychiatry. 2018 Feb 15;83(4):311-319. doi: 10.1016/j.biopsych.2017.08.010. Epub 2017 Aug 24.

Cerebral Hypoperfusion and Other Shared Brain Pathologies in Ischemic Stroke and Alzheimer's Disease

Dong S, Maniar S, Manole MD, Sun D.

Transl Stroke Res. 2018 Jun;9(3):238-250. doi: 10.1007/s12975-017-0570-2. Epub 2017 Oct 2.

Acetylcholinesterase Inhibitors: Beneficial Effects on Comorbidities in Patients With Alzheimer's Disease

Kaushik V, Smith ST, Mikobi E, Raji MA.

Am J Alzheimers Dis Other Demen. 2018 Mar;33(2):73-85. doi: 10.1177/1533317517734352. Epub 2017 Oct 3.

Neural stem cells and adult brain fatty acid metabolism: Lessons from the 3xTg model of Alzheimer's disease

Hamilton LK, Fernandes KJL.

Biol Cell. 2018 Jan;110(1):6-25. doi: 10.1111/boc.201700037. Epub 2017 Nov 15.

Food for thought: Leptin regulation of hippocampal function and its role in Alzheimer's disease

McGregor G, Harvey J.

Neuropharmacology. 2018 Jul 1;136(Pt B):298-306. doi: 10.1016/j.neuropharm.2017.09.038. Epub 2017 Oct 5.

Curcumin or bisdemethoxycurcumin for nose-to-brain treatment of Alzheimer disease? A bio/chemo-informatics case study

Hathout RM, El-Ahmady SH, Metwally AA.

Nat Prod Res. 2018 Dec;32(24):2873-2881. doi: 10.1080/14786419.2017.1385017. Epub 2017 Oct 12.

The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset

Panza F, Seripa D, Lozupone M, Solfrizzi V, Imbimbo BP, Barulli MR, Tortelli R, Capozzo R, Bisceglia P, Dimitri A, Stallone R, Dibello V, Quaranta N, Daniele A, Bellomo A, Greco A, Logroscino G.

Expert Opin Biol Ther. 2018 Jan;18(1):25-35. doi: 10.1080/14712598.2018.1389885. Epub 2017 Oct 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias